Press release
Neurological Disorder Drugs Market Size Forecasted To Achieve $114.65 Billion By 2029 With Steady Growth
Neurological Disorder Drugs
What Is the Neurological Disorder Drugs Market Size and Projected Growth Rate?
The neurological disorder drugs market has grown steadily. It is projected to increase from $84.6 billion in 2024 to $90.09 billion in 2025 at a CAGR of 6.5%. Contributing factors include therapeutic advancements, increased neurological disease incidence, government healthcare programs, and rising medical expenditures.
The neurological disorder drugs market is set to experience strong growth, reaching $114.65 billion by 2029 at a compound annual growth rate (CAGR) of 6.2%. This growth is attributed to expanding therapeutic options, disease-modifying treatments, the use of digital biomarkers, and the increasing prevalence of neurological disorders. Key trends include advancements in drug design, neuroimaging, genetic research, collaborations, and regenerative medicine.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=17207
What Are the Major Segments in the Neurological Disorder Drugs Market?
The neurological disorder drugs market covered in this report is segmented -
1) By Drug Class: Cholinesterase Inhibitors, N-Methyl-D-Aspartate (NMDA) Receptor Antagonists, Antiepileptic, Antipsychotic And Antidepressant, Other Drugs Classes
2) By Indication: Epilepsy, Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, Cerebrovascular Disease, Other Indications
3) By Route Of Administration: Oral, Parenteral, Other Routes Of Administration
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels
5) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End Users
Subsegtments:
1) By Cholinesterase Inhibitors: Donepezil, Rivastigmine, Galantamine
2) By N-Methyl-D-Aspartate (NMDA) Receptor Antagonists: Memantine, Other NMDA Receptor Antagonists
3) By Antiepileptic: Sodium Channel Blockers, GABA Enhancers, Glutamate Modulators, Other Antiepileptics
4) By Antipsychotic and Antidepressant: Risperidone, Olanzapine, SSRIs, SNRIs, Tricyclic
5) By Other Drug Classes: Dopaminergic Drugs, Alpha-2 Agonists, Immunomodulators, Other Neurological Disorder Medications
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=17207&type=smp
What Are The Driving Neurological Disorder Drugs Market Evolution?
The growing occurrence of neurological diseases is anticipated to support the expansion of the neurological disorder drugs market. These diseases stem from structural or chemical changes in the brain, spinal cord, or nerves and cause various symptoms. Their growing prevalence is linked to an aging population and increased exposure to environmental, metabolic, and lifestyle risk factors. Medications for neurological disorders help control symptoms, decelerate disease progression, and improve patients' long-term health. For instance, in September 2024, the Australian Institute of Health and Welfare projected that dementia cases in Australia will more than double from around 411,100 in 2023 to 849,300 by 2058, affecting 315,500 men and 533,800 women. Hence, the rising rate of neurological disorders is boosting demand for neurological disorder drugs.
Which Firms Dominate The Neurological Disorder Drugs Market Segments?
Major companies operating in the neurological disorder drugs market are F. Hoffmann-La Roche Ltd, Bayer AG, Sanofi S.A, AstraZeneca PLC, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company Pvt Ltd, Amgen Inc, Boehringer Ingelheim GmbH, Novo Nordisk A/S, Merck KGaA, Teva Pharmaceutical Industries Ltd, Otsuka America Pharmaceutical Inc, Biogen Inc, Bausch Health Companies Inc, Alexion Pharmaceuticals Inc., UCB S.A., Eisai Co Ltd, Cipla Inc, BioMarin Pharmaceutical Inc., Biocon Ltd, Acorda Therapeutics Inc.
What Neurological Disorder Drugs Market Trends Are Gaining Traction Across Different Segments?
Major companies in the neurological disorder drugs market are expanding treatment options with therapies like Ocrelizumab. In February 2024, Roche Holding AG, a Switzerland-based pharmaceutical company, introduced Ocrevus (Ocrelizumab) in India for treating both relapsing-remitting and primary progressive multiple sclerosis. Administered biannually, it targets CD20-positive B cells, reducing disease activity and progression.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/neurological-disorder-drugs-global-market-report
Which Is The Largest Region In The Neurological Disorder Drugs Market?
North America was the largest region in the neurological disorder drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neurological disorder drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Neurological Disorder Drugs Market?
2. What is the CAGR expected in the Neurological Disorder Drugs Market?
3. What Are the Key Innovations Transforming the Neurological Disorder Drugs Industry?
4. Which Region Is Leading the Neurological Disorder Drugs Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Neurological Disorder Drugs Market Size Forecasted To Achieve $114.65 Billion By 2029 With Steady Growth here
News-ID: 4041985 • Views: …
More Releases from The Business Research Company
Public Safety Network Slicing Market Overview, Current Trends, and Key Player An …
The public safety network slicing market is on track for remarkable expansion in the coming years, driven by technological advancements and increasing demand for efficient emergency communications. This growing sector is poised to play a critical role in enhancing the capabilities of public safety agencies through dedicated, secure network solutions tailored to their specific needs.
Projected Market Size and Growth Trajectory of the Public Safety Network Slicing Market
The public…
Competitive Analysis: Key Market Leaders and Emerging Participants in the Privat …
The private fifth generation (5G) network slicing market for yards is positioned for remarkable expansion as industries increasingly adopt advanced connectivity solutions tailored for complex operational environments. With rising demand for customized, secure, and low-latency communications, this sector is set to transform logistics, manufacturing, and related fields over the coming years.
Projected Market Value and Growth Trajectory for Private 5G Network Slicing for Yards
The private 5G network slicing market…
Segmentation, Major Trends, and Competitive Overview of the Policy Control Funct …
The policy control function analytics sector is emerging as a rapidly expanding market, driven by technological advancements and increasing network demands. With the ongoing evolution of communication networks and complex data environments, this industry is poised for significant growth and innovation. Let's explore the market size projections, leading companies, industry trends, and segment breakdown to understand the future landscape of this dynamic field.
Forecasted Market Size and Growth Trajectory of the…
Market Trend Analysis: The Impact of Recent Innovations on the Packet Optical Ne …
The packet optical networking equipment market is poised for significant expansion in the coming years as technological advancements and increasing data demands reshape the telecommunications landscape. This sector's growth is driven by evolving network architectures and the need for more efficient, high-capacity optical transport solutions. Let's explore the market's size projections, key players, influential trends, and segmentation details shaping its future.
Future Market Size Expectations for Packet Optical Networking Equipment …
More Releases for Drug
Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming…
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage
Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic…
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights:
* Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029
* Global and Regional Antibody Drug Conjugate Market Insight
* Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023
* Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight
* Insight On Antibody Drug Conjugates In Clinical Trials: > 550…
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
